News and Updates

Discover how the Uttar Pradesh Pharma and Medical Device Policy 2023 is set to transform the state into a global hub for healthcare manufacturing.

New clinical findings show Metaberine® improves metabolic health markers at a 200 mg daily dose. Learn how this breakthrough supports metabolic wellness.

The BathMat trial reveals how updated ICU bathing protocols can lower staff burnout, reduce nursing workload, and improve outcomes for critically ill patients.

Zipalertinib combination therapy meets key PFS endpoints in first-line EGFR exon 20 NSCLC, marking a major advancement in targeted lung cancer treatment.

Definium’s DT120 shows significant success in a Phase 3 anxiety trial, meeting primary endpoints and offering hope for new, effective GAD treatment options.

Discover how Generative AI is reshaping the clinical trials market, with projections hitting USD 1,986 billion by 2035. Learn about its impact on drug R&D.

Explore how the landmark CoMMpass Study is transforming multiple myeloma care through genomic profiling, targeted therapies, and personalized medicine.

New research shows AI integration can slash drug development costs by $21M per program. Discover how machine learning is transforming pharmaceutical R&D.

Discover how AI and digital health networks are breaking down barriers to clinical trials, improving patient recruitment, and accelerating medical research.

NeuroSense Therapeutics outlines its strategic goals for ALS research and PrimeC clinical development in a new update for investors and stakeholders.